Literature DB >> 2897848

Inhibition and photoinactivation of the bovine heart mitochondrial F1-ATPase by the cytotoxic agent, dequalinium.

S Zhuo1, W S Allison.   

Abstract

The bovine heart mitochondrial F1-ATPase is inhibited in the dark by the amphipathic cation, dequalinium, with a I0.5 of about 12 microM at pH 7.5. When illuminated at 350 nm in the presence of 1.7 microM dequalinium, the F1-ATPase is inactivated with a pseudo-first order rate constant of 7.9 X 10(-3) min-1. The apparent Kd of the dequalinium-enzyme complex was estimated to be about 12.5 microM by examining the rate of inactivation of the ATPase with 1.7-16.7 microM dequalinium. ATP, ADP, Pi, and Mg2+, singly or in combination, protected the ATPase against photoinactivation, with Mg2+ plus Pi being the most effective.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897848     DOI: 10.1016/s0006-291x(88)80378-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Functional sites in F1-ATPases: location and interactions.

Authors:  W S Allison; J M Jault; S Zhuo; S R Paik
Journal:  J Bioenerg Biomembr       Date:  1992-10       Impact factor: 2.945

Review 2.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 3.  From serendipity to mitochondria-targeted nanocarriers.

Authors:  Volkmar Weissig
Journal:  Pharm Res       Date:  2011-08-11       Impact factor: 4.200

4.  The TF1-ATPase and ATPase activities of assembled alpha 3 beta 3 gamma, alpha 3 beta 3 gamma delta, and alpha 3 beta 3 gamma epsilon complexes are stimulated by low and inhibited by high concentrations of rhodamine 6G whereas the dye only inhibits the alpha 3 beta 3, and alpha 3 beta 3 delta complexes.

Authors:  S R Paik; K Yokoyama; M Yoshida; T Ohta; Y Kagawa; W S Allison
Journal:  J Bioenerg Biomembr       Date:  1993-12       Impact factor: 2.945

5.  DQAsomes: a novel potential drug and gene delivery system made from Dequalinium.

Authors:  V Weissig; J Lasch; G Erdos; H W Meyer; T C Rowe; J Hughes
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

6.  Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens.

Authors:  Kristen M Smith; Alessandro Datti; Mayumi Fujitani; Natalie Grinshtein; Libo Zhang; Olena Morozova; Kim M Blakely; Susan A Rotenberg; Loen M Hansford; Freda D Miller; Herman Yeger; Meredith S Irwin; Jason Moffat; Marco A Marra; Sylvain Baruchel; Jeffrey L Wrana; David R Kaplan
Journal:  EMBO Mol Med       Date:  2010-09       Impact factor: 12.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.